Cryosurgery for prostate cancer
- Authors: Govorov A.V1, Vasilyev S.O1, Pushkar D.Y.1
-
Affiliations:
- A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation
- Issue: Vol 17, No 7 (2015)
- Pages: 29-32
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94318
- ID: 94318
Cite item
Full Text
Abstract
Cancer is the second most common cause of death only to cardiovascular diseases. In Russia, we marked the steady increase in the number of patients with malignant neoplasms last years, which were primarily due to increasing diagnostics and cancer overall survival rates. The development of the programme for the early prostate cancer screening in men older than 40 years lead to a significant incensement in the determination of the diseases at early stages. Prostate cancer (PC) frequency was higher in men over 60 years old, who often had intercurrent diseases, associated with severe course of the main disease during the radical methods of treatment. In such patients as well as in patients with life expectancies of less than 10 years, or in patients who had refused radical surgical treatment because of the possible complications, we had suggested the number of minimally invasive methods of treatment: cryoablation, HIFU treatment, photodynamic therapy, laser ablation, etc. The most studied PC treatment methods was cryoablation, which was recommended by the American and European Association of Urology as an alternative treatment. The received literature data, estimating the results of cryoablation showed the high recurrence-free survival rates.
Full Text
##article.viewOnOriginalSite##About the authors
A. V Govorov
A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation
Email: alexgovorov@newmail.ru
канд. мед. наук, доц. каф. урологии ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
S. O Vasilyev
A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation
Email: alexvasilyev@me.com
канд. мед. наук, ассистент каф. урологии ГБОУ ВПО МГМСУ им. А.И.Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
D. Yu Pushkar
A.I.Evdokimov Moscow State Medical and Dental University of the Ministry of Health of the Russian Federation
Email: pushkardm@mail.ru
д-р мед. наук, проф., зав. каф. урологии ГБОУ ВПО МГМСУ им. А.И. Евдокимова 127473, Russian Federation, Moscow, ul. Delegatskaia, d. 20, str. 1
References
- Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2013 году (заболеваемость и смертность). М.: МНИОИ им. П.А.Герцена, 2015.
- Dewar J. The Liquefaction of gases. Nature 1985; 51: 365-7.
- Patel B.G, Parsons C.L, Bidair M et al. Cryoablation for carcinoma of the prostate. J Surg Oncology 1996; 63: 256-64.
- Gonder M.J, Soanes Wa, Smith V. Experimental Prostate Cryosurgery. Invest Urol 1964; 14: 610-9. Gonder M.J, Soanes W.A, S. Shulman Cryosurgical treatment of the prostate. Invest Urol 1966; 3 (4): 372-8
- Фрейдович В.И., Фрейдович А.И. Криодеструкция предстательной железы. Мед. техника. 1970; 2: 55-7.
- Onik G.M, Cohen J.K, Reyes G.D et al. Transrectal ultrasound - guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993; 72: 1291-9.
- Lee F. US-guided percutaneous cryoablation of the prostate cancer. Radiology 1994; 192: 769-6.
- Cohen J.K, Miller R.J, Shuman B.A. Urethral warming catheter for use during cryoablation of the prostate. Urology 1995; 45: 861-4.
- Janzen N.K, Han K.R, Perry K.T et al. Feasibility of nerve - sparing prostate cryosurgery: applications and limitations in a canine model. J Endourol 2005; 19: 520-5.
- Clarke D.M, Baust J.M, Van Buskirk R.G et al. Chemo - cryocombination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology 2001; 42: 274-85.
- Wang H, Tu H.J, Qin J et al. Effect of cryotherapy and 5-fluorouracil on apoptosis of G422 glioma cells. Ai Zheng 2004; 23: 412-5.
- Jiang J, Goel R, Iftekhar M.A et al. Tumor necrosis factor - alpha - induced accentuation in cryoinjury: mechanisms in vitro and in vivo. Mol Cancer Ther 2008; 7: 2547-5.
- Baust J.M, Klossner D.P, Robilotto A et al. Vitamin D3 cryosensitization increases prostate cancer susceptibility to cryoablation via mitochondrial - mediated apoptosis and necrosis. BJU Int 2012; 109 (6): 949-58.
- Muldrew K, Rewcastle J, Donnelly B.J et al. Flounder antifreeze peptides increase the efficacy of cryosurgery. Cryobiology 2001; 42: 182-9.
- Burton S.A, Paljug W.R, Kalnicki S et al. Hypothermia - enhanced human tumor cell radiosensitivity. Cryobiology 1997; 35: 70-8.
- Говоров А.В., Васильев А.О., Пушкарь Д.Ю. Особенности криодеструкции предстательной железы. Мед. техника. 2015; 1: 40-5.
- Govorov A.V, Vasilyev A.O, Pushkar D.U. Specifics of Prostate Cryoablation. Biomedical Engineering 2015; 49 (1): 54-9.
- Говоров А.В., Васильев А.О., Иванов В.Ю. и др. Лечение рака предстательной железы при помощи криоаблации: проспективное исследование. Урология. 2014; 6: 69-74.
- Mottet N, Bastian P.J, Bellmunt J et al. Prostate cancer: guidelines. Netherlands: European Association of Urology, 2015.
- Koppie T.M, Shinohara K, Grossfeld G.D et al. The efficacy of cryosurgical ablation of the prostate cancer: the University of Carolina, San Francisco experience. J Urol 1999; 162 (2): 427-32.
- Long J.P, Bahn D, Lee F et al. Five - year retrospective, multi - institutional pooled analysis of cancer - related outcomes after cryosurgical ablation of the prostate. Urology 2001; 57 (3): 518-23.
- Donnelly B.J, Saliken J.C, Ernst D.S et al. Prospective trial of cryosurgical ablation of the prostate: five - year results. Urology 2002; 60 (4): 645-9.
- Jones J.S, Rewcastle J.C, Donnelly B.J et al. Whole gland primary prostate cryoablation: initial results from the Cryo On - line Data Registry. J Urol 2008; 180: 554-8.
- Cohen J.K, Miller R.J, Ahmed S et al. Ten - year biochemical disease control for patients with prostate cancer treated with cryosurgery as primary therapy. Urology 2008; 71: 515-8.
- Bahn D.K, Lee F, Badalament R et al. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60 (2A): 3-11.
Supplementary files
